Different TP53 mutants in p53 overexpressed epithelial ovarian carcinoma can be associated both with altered and unaltered glycolytic and apoptotic profiles
Abstract Background p53 is a tumor suppressor and key regulator of glycolysis in cancer cells, however highly mutated in tumors. In ovarian cancer, studies concerning p53 mutations focus on the DNA binding domain since the majority of hotspot mutations affects this region. Yet, mutations in other re...
Main Authors: | Stephanie Antoun, David Atallah, Roula Tahtouh, Nada Alaaeddine, Malak Moubarak, Abir Khaddage, Eliane Nasr Ayoub, George Chahine, George Hilal |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12935-018-0514-2 |
Similar Items
-
p53 expression as a prognostic marker in hepatocellular carcinoma
by: Cioca Andreea, et al.
Published: (2014-01-01) -
Estimating the protein burden limit of yeast cells by measuring the expression limits of glycolytic proteins
by: Yuichi Eguchi, et al.
Published: (2018-08-01) -
Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
by: Melania Tesio
Published: (2023-02-01) -
TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
by: Haiwei Wang, et al.
Published: (2022-06-01) -
TP53 in Myelodysplastic Syndromes
by: Yan Jiang, et al.
Published: (2021-10-01)